ArticleInvestigational new drugs2024
Study on the effects of rapamycin and the mTORC1/2 dual inhibitor OSI-027 on the metabolism of colon cancer cells based on UPLC-MS/MS metabolomics.
Kai Fan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.